A 28-year-old woman from rural Uttar Pradesh presents with acute-onset jaundice, severe abdominal pain, and vomiting at 8 weeks of gestation. Serum ALT is 2400 IU/L, bilirubin 9.5 mg/dL, PT-INR 2.8, and albumin 2.8 g/dL. Anti-HAV IgM and HBsAg are both negative. Which is the most appropriate confirmatory test for the suspected diagnosis?

## Clinical Presentation Analysis The patient presents with: - **Pregnancy (8 weeks gestation)** — critical risk factor - **Acute hepatitis** (markedly elevated ALT, hyperbilirubinemia) - **Signs of fulminant hepatic failure** (coagulopathy with PT-INR 2.8, hypoalbuminemia) - **Negative HAV and HBsAg** — rules out Hepatitis A and B - **Rural endemic area (Uttar Pradesh)** — HEV is hyperendemic ## Why HEV is the Diagnosis **Key Point:** Hepatitis E virus (HEV) causes the most severe acute hepatitis in **pregnant women**, particularly in the second and third trimester, with a mortality rate of 15–25% compared to <1% in non-pregnant individuals. ### HEV Epidemiology and Clinical Features | Feature | HEV in Pregnancy | HEV in Non-Pregnant | Other Viruses | |---------|------------------|-------------------|----------------| | **Severity** | Fulminant hepatitis (15–25% mortality) | Mild to moderate (0.5–3% mortality) | Mild (except HDV) | | **Trimester** | 2nd/3rd trimester worst | N/A | N/A | | **Geographic** | Hyperendemic in South Asia, Africa | Same | N/A | | **Vertical transmission** | High (50–100% to fetus) | N/A | Low (except HBV) | | **Coagulopathy** | Marked (PT-INR often >2) | Mild | Variable | **High-Yield:** HEV in pregnancy = fulminant hepatitis with coagulopathy and high fetal loss. ### Diagnostic Confirmation for HEV **Anti-HEV IgM:** - Appears early in acute infection (first 2–3 weeks) - Highly specific for acute HEV - Most practical first-line test **HEV RNA by RT-PCR:** - Gold standard for confirming HEV infection - Detects viral RNA in serum/stool - Quantifies viral load - Essential in pregnancy to assess severity and fetal risk **Clinical Pearl:** In a pregnant woman with fulminant hepatitis, negative HAV/HBsAg, and endemic exposure, Anti-HEV IgM + HEV RNA is diagnostic and guides obstetric management (risk of preterm labor, fetal loss, neonatal transmission). ## Pathophysiology of HEV in Pregnancy ```mermaid flowchart TD A[HEV infection in pregnancy]:::outcome --> B[Viral replication in hepatocytes]:::action B --> C[Massive hepatocyte necrosis]:::action C --> D[Loss of synthetic function]:::outcome D --> E[Coagulopathy & hypoalbuminemia]:::outcome D --> F[Encephalopathy risk]:::urgent A --> G[Vertical transmission to fetus]:::urgent G --> H[Preterm labor/fetal loss]:::urgent ``` **Mnemonic:** **HEP** = **H**epatitis E in **P**regnancy (severe, fulminant, South Asian endemic).